The invention encompasses compounds of formula I, including pharmaceutica lly acceptable salts, as well as compositions and methods of using. these co mpounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
申请公布号
CA2681093(A1)
申请公布日期
2008.09.18
申请号
CA20082681093
申请日期
2008.03.05
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
GENTLES, ROBERT G.;YEUNG, KAP-SUN;ZHENG, XIAOFAN;HAN, YING;TU, YONG;DING, MIN;HEWAWASAM, PIYASENA;GRANT-YOUNG, KATHARINE A.;HUDYMA, THOMAS W.;BENDER, JOHN A.;KADOW, JOHN F.
